Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Primary Care
•
Geriatric Medicine
•
Dementia
Have results from recent quasi-experimental trials around herpes zoster vaccination and dementia risk/progression affected your clinical practice?
https://jamanetwork.com/journals/jama/fullarticle/2833335
Related Questions
What are your thoughts about lion's mane supplementation to slow the decline or improve cognitive capacity for those at risk of dementia?
How have the results of the U.S. POINTER study involving multidomain lifestyle interventions to protect cognitive function influenced your practice?
Do you recommend for/against use of AI chatbot companions to improve quality of life for older adults with cognitive impairment?
How do you determine whether to continue anti-dementia medications (such as cholinesterase inhibitors) for patients with dementia when enrolling in hospice?
In older adults with mild cognitive impairment, do you ever prescribe cholinesterase inhibitors and/or memantine?
How do you choose among SSRIs and dosing strategies for the management of behavioral and psychological symptoms of dementia?
What is your approach to deprescribing gabapentinoids so as to prevent withdrawal effects?
How do you differentiate cognitive impairment from normal age-related cognitive decline?
What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?